SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001575705-22-000657
Filing Date
2022-09-13
Accepted
2022-09-13 17:03:03
Documents
17
Period of Report
2022-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 spk_8k.htm   iXBRL 8-K 45010
2 ex1_1.htm EX-1.1 13243
3 ex3_1.htm EX-3.1 9726
4 ex10_1.htm EX-10.1 22892
5 ex99_1.htm EX-99.1 34140
  Complete submission text file 0001575705-22-000657.txt   371699

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE spk-20220908.xsd EX-101.SCH 3387
7 XBRL DEFINITION FILE spk-20220908_def.xml EX-101.DEF 26850
8 XBRL LABEL FILE spk-20220908_lab.xml EX-101.LAB 36914
9 XBRL PRESENTATION FILE spk-20220908_pre.xml EX-101.PRE 25470
11 EXTRACTED XBRL INSTANCE DOCUMENT spk_8k_htm.xml XML 6319
Mailing Address ROOM 368, 302 BUWEI 211 FUTE NORTH ROAD, SHANGHAI F4 200131
Business Address ROOM 368, 302 BUWEI 211 FUTE NORTH ROAD, SHANGHAI F4 200131 86 13439129879
SPK Acquisition Corp. (Filer) CIK: 0001848097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40462 | Film No.: 221241393
SIC: 2836 Biological Products, (No Diagnostic Substances)